Acadesine
Acadesine (also known as AICAR, 5-Aminoimidazole-4-carboxamide ribonucleotide) is an adenosine monophosphate-activated protein kinase (AMPK) activator. It is a synthetic compound that has been studied for its potential therapeutic effects in various medical conditions, including ischemia, diabetes, and cancer.
Mechanism of Action
Acadesine works by mimicking the effects of adenosine monophosphate (AMP) in the body. It activates the AMP-activated protein kinase (AMPK) pathway, which plays a crucial role in cellular energy homeostasis. Activation of AMPK leads to increased glucose uptake, fatty acid oxidation, and mitochondrial biogenesis, which can be beneficial in conditions characterized by impaired energy metabolism.
Medical Applications
Ischemia
Acadesine has been investigated for its potential to protect against ischemic injury, particularly in the context of myocardial infarction (heart attack). By activating AMPK, Acadesine can enhance the heart's ability to cope with reduced blood flow and oxygen supply, potentially reducing the extent of tissue damage.
Diabetes
In diabetes, particularly type 2 diabetes, Acadesine's ability to improve glucose uptake and enhance insulin sensitivity makes it a compound of interest. Studies have shown that Acadesine can help lower blood glucose levels and improve metabolic profiles in diabetic models.
Cancer
Acadesine has also been explored for its anti-cancer properties. By activating AMPK, it can inhibit the growth of cancer cells and induce apoptosis (programmed cell death). This makes it a potential candidate for cancer therapy, although more research is needed to fully understand its efficacy and safety in this context.
Research and Development
Acadesine has undergone various stages of clinical trials, particularly for its cardioprotective effects during coronary artery bypass grafting (CABG) surgery. However, its development has faced challenges, and it is not currently approved for clinical use.
See Also
- AMP-activated protein kinase
- Ischemia
- Diabetes
- Cancer
- Myocardial infarction
- Coronary artery bypass grafting
References
External Links
-
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD